Abstract: The present disclosure relates to a method for reducing and homogenizing residual stress of a component, which comprises: detecting stress value(s) of regulation portion(s) of the component; placing the component in a container containing a fluid medium so as to immerse the component in the fluid medium; emitting, by an acoustic wave generator, an elastic wave to the fluid medium in a manner of emitting towards the regulation portion(s) of the component, and determining an emitting period of time and a frequency of the elastic wave based on the stress value(s); returning to the step S1 when the emitting period of time has elapsed, until the stress value(s) is stable. The method and the device solve the problems that it is difficult to reduce and homogenize the residual stress on high-precision machined components, complex structural components, thin-walled structural components, and low-stiffness components.

Abstract: Embodiments of the present disclosure provide a control method, configured to control a smart mirror (100). The smart mirror (100) comprises a camera (20). The control method comprises: controlling the camera (20) to capture a current user; determining whether the current user is a registered user; enabling the current user to log into the smart mirror (100) when the current user is a registered user; controlling the smart mirror (100) to generate interaction with the current user and output interactive information according to an input of the current user. Embodiments of the present disclosure also provide a controller (10), a smart mirror (100) and a computer readable storage medium.

Abstract: The present invention provides dialkyl ether compounds and pharmaceutically acceptable salts thereof, compositions containing the same and one or more active agents, and methods of administering active agents with the same.

Abstract: The present invention relates to pharmaceutical compounds for delivering active agents, such as biologically or chemically active agents, to a target. The invention also relates to pharmaceutical compositions comprising at least one delivery agent compound of the present invention and at least one active agent, and unit dosage forms comprising such compositions. Methods for the preparation and administration of the pharmaceutical compositions are also disclosed.

Abstract: Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.

Abstract: An isolating self-oscillation flyback converter includes a coupling transformer T1, a FET TR1, a transistor TR2, a photoelectric coupling isolator OC1 and a load feedback circuit Adj. The common polarity terminal of a feedback winding Nfb of the coupling transformer T1 is connected to the gate of the FET TR1 via a capacitance C1 and a resistance R2, and connected to the base of the transistor TR2 via a capacitance C2. The base of the transistor TR2 is also connected to the emitter of the photoelectric coupling isolator OC1. The photoelectric coupling isolator OC1 is connected to the positive terminal of the output voltage. The opposite polarity terminal of the feedback winding Nfb is connected to the collector of the photoelectric coupling isolator OC1 via a resistance R5, and connected to ground via a capacitance C5. The common polarity terminal of the feedback winding Nfb is also connected to the cathode of a diode D, and the anode of the diode D is connected to ground.

Abstract: An isolating self-oscillation flyback converter includes a coupling transformer T1, a FET TR1, a transistor TR2, a photoelectric coupling isolator OC1 and a load feedback circuit Adj. The common polarity terminal of a feedback winding Nfb of the coupling transformer T1 is connected to the gate of the FET TR1 via a capacitance C1 and a resistance R2, and connected to the base of the transistor TR2 via a capacitance C2. The base of the transistor TR2 is also connected to the emitter of the photoelectric coupling isolator OC1. The photoelectric coupling isolator OC1 is connected to the positive terminal of the output voltage. The opposite polarity terminal of the feedback winding Nfb is connected to the collector of the photoelectric coupling isolator OC1 via a resistance R5, and connected to ground via a capacitance C5. The common polarity terminal of the feedback winding Nfb is also connected to the cathode of a diode D, and the anode of the diode D is connected to ground.

Abstract: The present invention relates to pharmaceutical compounds for delivering active agents, such as biologically or chemically active agents, to a target. The invention also relates to pharmaceutical compositions comprising at least one delivery agent compound of the present invention and at least one active agent, and unit dosage forms comprising such compositions. Methods for the preparation and administration of the pharmaceutical compositions are also disclosed.

Abstract: The present invention provides propyl phenoxy ether compounds and pharmaceutically acceptable salts thereof, compositions containing the same and one or more active agents, and methods of administering active agents with the same. The delivery agents of the present invention are well suited for forming non-covalent mixtures with active agents for oral, intracolonic, pulmonary, and other routes of administration to animals.

Abstract: The present invention provides dialkyl ether compounds and pharmaceutically acceptable salts thereof, compositions containing the same and one or more active agents, and methods of administering active agents with the same.

Abstract: Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.